Clinical Trials on Epithelial Ovarian in United Kingdom
Total 11333 results
-
Syndax PharmaceuticalsPfizer; Merck KGaA, Darmstadt, GermanyCompletedStudy of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian CancerFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States
-
Medical College of WisconsinMerck Sharp & Dohme LLC; The Cleveland ClinicCompleted
-
Verastem, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...Active, not recruitingOvarian Cancer | Low Grade Ovarian Serous AdenocarcinomaSpain, United States, Belgium, United Kingdom, France, Canada, Italy
-
University of ManchesterCancer Research UK; Centre for Trials Research, Cardiff UniversityRecruitingOvary CancerUnited Kingdom
-
Boehringer IngelheimCompleted
-
Power Life Sciences Inc.Not yet recruitingRecurrent Ovarian CancerUnited States
-
Baylor College of MedicineThe University of Texas Health Science Center, Houston; University of Texas... and other collaboratorsRecruitingQuality of Life | Depressive Symptoms | Ovarian NeoplasmUnited States
-
University of BirminghamRecruitingPolycystic Ovary SyndromeUnited Kingdom
-
South Plains Oncology ConsortiumTerminatedOvarian Cancer | Cancer of the Ovary | Primary Peritoneal Carcinoma | Ovary Neoplasms | Cancer of OvaryUnited States
-
Georgetown UniversityCompletedHereditary Breast and Ovarian CancerUnited States
-
AstraZenecaParexelWithdrawnOvarian CancerUnited States, Italy, Canada, Spain
-
Yale UniversityNational Cancer Institute (NCI); University of MiamiRecruiting
-
AstraZenecaCompletedAdvanced Ovarian Cancer | Paclitaxel | Carboplatin | Triple Negative Metastatic Breast CancerBelgium, Netherlands, United Kingdom
-
M.D. Anderson Cancer CenterMereo BioPharmaRecruiting
-
National Cancer Institute (NCI)CompletedOvarian Neoplasms | Ovarian Cancer | Cancer of the OvaryUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Peritoneal Cavity CancerUnited States
-
zr Pharma & GmbHFoundation MedicineCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited Kingdom, United States, Israel, Spain, Italy, Czechia, Canada, Hungary, Poland, Russian Federation, Brazil, Ukraine
-
MEI Pharma, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States, Australia
-
Yale UniversityR-Pharm-US, LLCCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedOvarian Cancer | Primary Peritoneal Cancer | Recurrent Ovarian Cancer | Fallopian TubeUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedOvarian Cancer | Peritoneal Cavity CancerUnited States
-
MorphotekEisai Europe Ltd. (United Kingdom)TerminatedOvarian CancerUnited States, Hong Kong, Netherlands, Spain, Korea, Republic of, Belgium, Taiwan, Israel, Japan, France, United Kingdom, Singapore, Italy, Argentina, India, Germany, Hungary, Australia, Portugal, Russian Federation, Canada, Poland, Greec... and more
-
Eli Lilly and CompanyCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerItaly, United States, Russian Federation
-
AA SecordBoehringer IngelheimCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
AstraZenecaCompletedOvarian CancerCanada, Czechia, Poland, Romania, United States, Belgium, France, Russian Federation, United Kingdom, Israel, Spain, Germany, Austria, Netherlands, Australia, Estonia, Ukraine
-
Yale UniversityGilead SciencesRecruitingOvarian CarcinomaUnited States
-
University of HullNot yet recruitingPolycystic Ovary SyndromeUnited Kingdom
-
Northwestern UniversityNational Cancer Institute (NCI); Ipsen BiopharmaceuticalsCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian Carcinoma | Refractory Fallopian Tube... and other conditionsUnited States
-
AGO Research GmbHARCAGY/ GINECO GROUP; Australia New Zealand Gynaecological Oncology Group; Arbeitsgemeinschaft... and other collaboratorsCompletedRecurrent Platinum-sensitive Ovarian CancerFrance, Belgium, Germany, Australia, United Kingdom, Austria
-
NorthShore University HealthSystemL-Nutra IncNot yet recruitingOvarian Cancer | Chemotherapeutic ToxicityUnited States
-
NX Development CorpRecruitingOvarian CancerUnited States
-
Haider MahdiMerck Sharp & Dohme LLC; ALX OncologyRecruiting
-
H. Lee Moffitt Cancer Center and Research InstituteAnixa Biosciences, Inc.RecruitingOvarian CancerUnited States
-
Virginia Commonwealth UniversityGlaxoSmithKline; Puma Biotechnology, Inc.RecruitingOvarian Cancer | Advanced Solid TumorUnited States
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT); US Oncology... and other collaboratorsCompletedA Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian CancerOvarian Neoplasms | Platinum Sensitive Ovarian CancerUnited States, Belgium, Sweden, Germany, Israel, Austria, Canada, Denmark, Spain, Italy, United Kingdom, Poland, France, Hungary, Norway
-
European Organisation for Research and Treatment...CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerFrance, Spain, Netherlands, Australia, United Kingdom, Italy, Portugal, Austria
-
ImunonActive, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States, Canada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Rigel Pharmaceuticals; Allegheny Singer Research Institute (also known as Allegheny...Active, not recruitingOvarian CancerUnited States
-
Imperial College LondonNorth Eastern German Society of Gynaecological Oncology; Takeda Pharmaceuticals...Active, not recruitingOvarian Neoplasms | Fallopian Tube Neoplasms | Ovarian Cancer | Fallopian Tube Cancer | Ovarian Endometrioid Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Primary Peritoneal Carcinoma | Ovarian CarcinosarcomaUnited Kingdom, Germany
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); University of Pittsburgh; AIM ImmunoTech Inc.SuspendedOvarian Cancer | Cancer of the Ovary | Ovary Cancer | Neoplasms, Ovarian | Ovary Neoplasms | Cancer of OvaryUnited States
-
BayerCompletedOvarian NeoplasmsUnited States, Canada
-
M.D. Anderson Cancer CenterRecruitingOvarian Carcinoma | Primary Peritoneal Carcinoma | Malignant Ovarian Neoplasm | Low Grade Ovarian Serous Adenocarcinoma | Primary Peritoneal Low Grade Serous Adenocarcinoma | PsammocarcinomaUnited States
-
William CarsonCompletedHepatocellular Carcinoma | Unspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell TumorUnited States
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.CompletedRecurrent Platinum Resistant Ovarian CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States
-
Loyola UniversityMedical University of South Carolina; Cures Within ReachRecruitingOvarian CancerUnited States
-
Northwestern UniversityRecruitingOvarian Cancer | Prehabilitation | Neoadjuvant ChemotherapyUnited States
-
Sumitomo Pharma America, Inc.TerminatedCancer | Ovarian CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Southeastern Gynecologic OncologyCelgene CorporationCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States